CONMED Earnings Estimate

CNMD Stock  USD 67.69  0.83  1.24%   
The next projected EPS of CONMED is estimated to be 1.007375 with future projections ranging from a low of 1.005 to a high of 1.01. CONMED's most recent 12-month trailing earnings per share (EPS TTM) is at 4.22. Please be aware that the consensus of earnings estimates for CONMED is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
CONMED is projected to generate 1.007375 in earnings per share on the 31st of December 2024. CONMED earnings estimates show analyst consensus about projected CONMED EPS (Earning Per Share). It derives the highest and the lowest estimates based on CONMED's historical volatility. Many public companies, such as CONMED, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

CONMED Revenue Breakdown by Earning Segment

By analyzing CONMED's earnings estimates, investors can diagnose different trends across CONMED's analyst sentiment over time as well as compare current estimates against different timeframes. At present, CONMED's Pretax Profit Margin is projected to slightly decrease based on the last few years of reporting.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

CONMED Earnings Estimation Breakdown

The calculation of CONMED's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CONMED is estimated to be 1.007375 with the future projection ranging from a low of 1.005 to a high of 1.01. Please be aware that this consensus of annual earnings estimates for CONMED is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
1.05
1.00
Lowest
Expected EPS
1.007375
1.01
Highest

CONMED Earnings Projection Consensus

Suppose the current estimates of CONMED's value are higher than the current market price of the CONMED stock. In this case, investors may conclude that CONMED is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CONMED's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2024Current EPS (TTM)
783.62%
1.05
1.007375
4.22

CONMED Earnings History

Earnings estimate consensus by CONMED analysts from Wall Street is used by the market to judge CONMED's stock performance. Investors also use these earnings estimates to evaluate and project the stock performance into the future in order to make their investment decisions. However, we recommend analyzing not only CONMED's upcoming profit reports and earnings-per-share forecasts but also comparing them to our different valuation methods.

CONMED Quarterly Gross Profit

179 Million

The current year's Retained Earnings is expected to grow to about 546.4 M, whereas Retained Earnings Total Equity is forecasted to decline to about 467.3 M. As of January 18, 2025, Common Stock Shares Outstanding is expected to decline to about 25.9 M. The current year's Net Loss is expected to grow to about (68.9 M).
Hype
Prediction
LowEstimatedHigh
65.7567.8069.85
Details
Intrinsic
Valuation
LowRealHigh
60.9274.9276.97
Details
7 Analysts
Consensus
LowTargetHigh
73.8481.1490.07
Details
Note that many institutional investors and large investment bankers can move markets due to the volume of CONMED assets they manage. They also follow analysts to some degree and often drive overall investor sentiments towards CONMED. With so many stockholders watching consensus numbers, the difference between actual and projected earnings is one of the most critical factors driving CONMED's stock price in the short term.

CONMED Earnings per Share Projection vs Actual

Actual Earning per Share of CONMED refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering CONMED predict the company's earnings will be in the future. The higher the earnings per share of CONMED, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

CONMED Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as CONMED, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of CONMED should always be considered in relation to other companies to make a more educated investment decision.

CONMED Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact CONMED's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-10-30
2024-09-300.991.050.06
2024-07-31
2024-06-300.910.980.07
2024-04-24
2024-03-310.740.790.05
2024-01-08
2023-12-311.111.06-0.05
2023-10-25
2023-09-300.830.90.07
2023-07-26
2023-06-300.790.830.04
2023-04-26
2023-03-310.60.660.0610 
2023-02-02
2022-12-310.90.42-0.4853 
2022-10-26
2022-09-300.750.770.02
2022-07-27
2022-06-300.750.760.01
2022-05-04
2022-03-310.620.70.0812 
2022-01-26
2021-12-311.031.070.04
2021-10-27
2021-09-300.750.80.05
2021-07-28
2021-06-300.620.710.0914 
2021-04-28
2021-03-310.440.630.1943 
2021-01-27
2020-12-310.760.840.0810 
2020-10-28
2020-09-300.230.880.65282 
2020-07-29
2020-06-30-0.95-0.070.8892 
2020-04-29
2020-03-310.460.510.0510 
2020-01-29
2019-12-310.890.90.01
2019-10-30
2019-09-300.560.620.0610 
2019-07-31
2019-06-300.530.560.03
2019-04-24
2019-03-310.540.570.03
2019-01-22
2018-12-310.720.730.01
2018-11-01
2018-09-300.460.460.0
2018-08-01
2018-06-300.450.460.01
2018-04-25
2018-03-310.440.530.0920 
2018-01-31
2017-12-310.650.690.04
2017-11-02
2017-09-300.410.420.01
2017-07-26
2017-06-300.410.410.0
2017-04-26
2017-03-310.350.380.03
2017-02-01
2016-12-310.560.54-0.02
2016-10-27
2016-09-300.40.410.01
2016-07-27
2016-06-300.460.470.01
2016-04-27
2016-03-310.410.420.01
2016-01-27
2015-12-310.510.520.01
2015-10-21
2015-09-300.430.38-0.0511 
2015-07-21
2015-06-300.440.36-0.0818 
2015-04-22
2015-03-310.430.42-0.01
2015-01-27
2014-12-310.540.53-0.01
2014-10-23
2014-09-300.390.440.0512 
2014-07-23
2014-06-300.470.470.0
2014-04-24
2014-03-310.470.490.02
2014-02-13
2013-12-310.490.530.04
2013-10-24
2013-09-300.40.40.0
2013-07-24
2013-06-300.440.43-0.01
2013-04-25
2013-03-310.450.450.0
2013-02-14
2012-12-310.50.520.02
2012-10-25
2012-09-300.40.430.03
2012-07-26
2012-06-300.450.43-0.02
2012-04-26
2012-03-310.440.43-0.01
2012-02-15
2011-12-310.40.460.0615 
2011-10-27
2011-09-300.320.330.01
2011-07-28
2011-06-300.350.350.0
2011-04-28
2011-03-310.310.370.0619 
2011-02-03
2010-12-310.360.360.0
2010-10-28
2010-09-300.30.340.0413 
2010-07-29
2010-06-300.260.320.0623 
2010-04-29
2010-03-310.260.280.02
2010-02-04
2009-12-310.30.370.0723 
2009-10-22
2009-09-300.160.280.1275 
2009-07-30
2009-06-300.150.170.0213 
2009-04-28
2009-03-310.240.19-0.0520 
2009-02-05
2008-12-310.290.340.0517 
2008-10-23
2008-09-300.330.370.0412 
2008-07-24
2008-06-300.390.430.0410 
2008-04-24
2008-03-310.370.40.03
2008-02-07
2007-12-310.380.440.0615 
2007-10-25
2007-09-300.290.290.0
2007-07-26
2007-06-300.310.350.0412 
2007-04-26
2007-03-310.260.30.0415 
2007-02-08
2006-12-310.230.30.0730 
2006-10-26
2006-09-300.190.220.0315 
2006-07-25
2006-06-300.20.230.0315 
2006-04-27
2006-03-310.170.180.01
2006-02-09
2005-12-310.270.18-0.0933 
2005-10-25
2005-09-300.310.320.01
2005-07-26
2005-06-300.450.450.0
2005-04-28
2005-03-310.470.46-0.01
2005-02-10
2004-12-310.460.490.03
2004-10-21
2004-09-300.370.380.01
2004-07-22
2004-06-300.410.410.0
2004-04-22
2004-03-310.420.4-0.02
2004-01-29
2003-12-310.420.460.04
2003-10-24
2003-09-300.360.32-0.0411 
2003-07-17
2003-06-300.350.350.0
2003-04-24
2003-03-310.350.350.0
2003-02-11
2002-12-310.320.320.0
2002-10-17
2002-09-300.320.320.0
2002-07-18
2002-06-300.330.330.0
2002-04-23
2002-03-310.340.350.01
2002-02-06
2001-12-310.30.320.02
2001-10-17
2001-09-300.220.220.0
2001-07-19
2001-06-300.240.310.0729 
2001-04-25
2001-03-310.260.260.0
2001-02-08
2000-12-310.250.290.0416 
2000-10-19
2000-09-300.350.12-0.2365 
2000-07-25
2000-06-300.180.190.01
2000-04-25
2000-03-310.320.320.0
2000-02-10
1999-12-310.330.330.0
1999-10-21
1999-09-300.290.290.0
1999-07-22
1999-06-300.290.290.0
1999-04-15
1999-03-310.270.270.0
1999-02-10
1998-12-310.280.280.0
1998-10-21
1998-09-300.260.260.0
1998-07-23
1998-06-300.20.20.0
1998-04-22
1998-03-310.190.190.0
1998-02-10
1997-12-310.220.220.0
1997-10-21
1997-09-300.190.20.01
1997-07-22
1997-06-300.150.150.0
1997-04-17
1997-03-310.190.17-0.0210 
1997-02-11
1996-12-310.210.210.0
1996-10-24
1996-09-300.180.180.0
1996-07-22
1996-06-300.190.190.0
1996-04-22
1996-03-310.170.170.0
1996-01-30
1995-12-310.180.180.0
1995-10-16
1995-09-300.160.160.0

About CONMED Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of CONMED earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current CONMED estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as CONMED fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings520.4 M546.4 M
Retained Earnings Total Equity474.5 M467.3 M
Earnings Yield 0.02  0.02 
Price Earnings Ratio 46.89  40.63 
Price Earnings To Growth Ratio(0.34)(0.35)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CONMED. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.14
Dividend Share
0.8
Earnings Share
4.22
Revenue Per Share
41.821
Quarterly Revenue Growth
0.04
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.